Cerflux Inc.

Birmingham, AL

UEI
RJKTP1C2LNJ8
CAGE
84JT5
Primary NAICS
Not on record
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Subcontinent Asian (Asian-Indian) American Owned
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
215 Richard Arrington Jr Blvd N Suite 101, Birmingham, AL 35203, USA
Website
cerflux.com
Founded
2018
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Health Care
  2. Health Care Equipment & Services
  3. Health Care Providers & Services
SIC code
38 Instruments & Related Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Cerflux Inc.'s 3 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Sbir phase II: predictive EX vivo solid tumor new approach method (NAM) for screening anticancer agents -the broader… Grant · 2545371 National Science Foundation $1,250,000
Sbir phase i: predictive EX vivo solid tumor biopsy-chip multiplexer for screening anticancer agents -the broader… Grant · 2321805 National Science Foundation $275,000
Development of personalized EX vivo predictive technology for rapidly matching patient tumors with chemotherapy regimens… Grant · R43CA254493 National Cancer Institute $405,148

Quick answers

What is Cerflux Inc.'s UEI?

Cerflux Inc.'s Unique Entity ID (UEI) in SAM.gov is RJKTP1C2LNJ8.

What is Cerflux Inc.'s CAGE code?

Cerflux Inc.'s CAGE code is 84JT5.

Where is Cerflux Inc. located?

Cerflux Inc.'s physical address in SAM.gov is 215 Richard Arrington Jr Blvd N Suite 101, Birmingham, AL 35203, USA.

Is Cerflux Inc. registered in SAM.gov?

Yes. Cerflux Inc.'s SAM.gov registration is active through September 22, 2027.

What is Cerflux Inc.'s most recent federal award?

Cerflux Inc.'s most recent federal grant award is Sbir phase II: predictive EX vivo solid tumor new approach method (NAM) for screening anticancer agents -the broader… (2545371), from National Science Foundation, on August 1, 2026.

On GovTribe

See Cerflux Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login